Organization
Boston Biomedical, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Boston Biomedical, Inc.
... Boston Biomedical, Inc., an industry leader in the development of next-generation cancer therapeutics, today ...
... Boston Biomedical, Inc., an industry leader in the development of next-generation cancer therapeutics, today ...
... Boston Biomedical, Inc., an industry leader in the development of next-generation cancer therapeutics, today ...
... Boston Biomedical, Inc., an industry leader in the development of next-generation cancer therapeutics designed ...
... Boston Biomedical, Inc., today announced that the BRIGHTER Trial evaluating the efficacy and safety ...
... ASA, Bio-Path Holdings Inc, BioLineRx Ltd, BioLite Inc, Boehringer Ingelheim GmbH, Boston Biomedical Inc, Bristol-Myers Squibb Company, Calithera Biosciences Inc, Cantex Pharmaceuticals Inc, Celgene Corp, ...
... The company is pleased to share that Patricia S. Andrews, CEO of Boston Biomedical, has joined the Board of Directors of GlycoMimetics, Inc., a clinical-stage ...
... the appointment ofPatricia S. Andrews, chief executive officer and director of Boston Biomedical, Inc., to its Board of Directors. "It's an asset to our Board ...
... Boston Biomedical, Inc. has announced that it will present data from a Phase Ib/II ...
... Boston Biomedical, Inc., an industry leader in the development of next-generation cancer therapeutics designed ...
... Boston Biomedical, Inc., an industry leader in the development of next-generation cancer therapeutics designed ...
... Inc, AVEO Pharmaceuticals Inc, Bayer AG, BeiGene Ltd, Boehringer Ingelheim GmbH, Boston Biomedical Inc, Bristol-Myers Squibb Company, Celgene Corp, Celldex Therapeutics Inc, Celsion Corp, CerRx ...
... Boston Biomedical, an industry leader in the development of next-generation cancer therapeutics designed ...
... Boston Biomedical, an industry leader in the development of next-generation cancer therapeutics designed ...
... Boston Biomedical, an industry leader in the development of next-generation cancer therapeutics designed ...
... �Boston Biomedical, an industry leader in the development of next-generation cancer therapeutics designed ...
... the new videos,Pat Andrews, Executive Vice President and Chief Operating Officer at Boston Biomedical, andSune Kok, Head of Business Intelligence at QVARTZ, are rethinking how ...
... Bionovis SA, Biothera Pharmaceutical Inc, Blueprint Medicines Corp, Boehringer Ingelheim GmbH, Boston Biomedical Inc, Bristol-Myers Squibb Company, Calithera Biosciences Inc etc. Order a Purchase Copy ...
... Boston Biomedical, an industry leader in the development of novel compounds designed to ...
... Boards of Directors of its consolidated subsidiaries in the United States, Boston Biomedical, Inc. 'BBI' and Boston Biomedical Pharma, Inc. 'BBP', had resolved to effect ...
... Boston Biomedical, an industry leader in the development of novel compounds designed to ...
... �Boston Biomedical, an industry leader in the development of novel compounds designed to ...
... �Boston Biomedical, an industry leader in the development of novel compounds designed to ...
... Biocon Limited, Bionomics Limited, Bionovis SA, Biotecnol, Inc., Boehringer Ingelheim GmbH, Boston Biomedical, Inc., Bristol-Myers Squibb Company, Burzynski Research Institute, Inc., Calithera Biosciences, Inc., Carna ...
Want to see the full history of news? Upgrade to RelSci Professional now!
Start My Free Trial